Thomas Carr Blog | MDCA - Recent Breakout Is A Buying Opportunity | TalkMarkets
Founder, CEO of DrStoxx
Contributor's Links: Dr. Stoxx Dr. Stoxx Trading
Dr. Thomas K. Carr (aka “Dr Stoxx”) is the Founder of DrStoxx.com (formerly “Befriend the Trend Trading”). He holds M.Phil. and D.Phil. degrees from the University of Oxford. For 16 years he was a tenured professor and department chair. He currently is a fulltime trader, ...more

MDCA - Recent Breakout Is A Buying Opportunity

Date: Tuesday, July 25, 2017 12:14 AM EDT

I run a series of momentum stock scans each market day, and my most profitable of these is my "TOP 3 HOT STOXX SCAN."  This is the scan that lies behind our brand-new HOT STOXX LETTER  This momentum system is designed to buy the 3 best stocks in the entire universe of stocks based on market cap (under $2B), low key valuation metrics, strong peer industry standards, strong sales growth, and, of course, strong price momentum over 3 time frames.

Our "TOP 3 HOT STOCKS SCAN" and the trading system that goes with it has an historical performance record of +158.3% average ROI per year for the past 7 years.  

For the past couple of weeks, MDCA has shown up on this scan.  Subscribers to the letter are now long the stock and are enjoying its recent breakout run.  I believe this run is just getting started.  Let's look at the numbers:

Company Name: MDC Partners

Market Cap: $592M (smallcap)

Profile: MDC Partners is a Canadian company does marketing, customer service management, branding, social media, and e-commerce management for mid and large size companies.   They serve over 1700 clients worldwide.   They operate on a "partner" model which allows their best talent to flourish entrepreneurially.  

Analyst Support: a recent upgrade from Jefferies from Hold to Buy, and a raised price target from Wedbush.  The "business services" sector has been super hot this earnings season, with 67% beating earnings estimates and 100% of companies reporting beating sales estimates.  

Why I Like the Stock: in addition to showing up on my scans, I particularly like shares of MDCA here for the following reasons:

  • shares trade at only 0.4x sales and only 12x free cash flow, suggesting a healthy balance sheet
  • EPS grew 55% last quarter and are expected to grow +113% in 2018
  • shares pay an 8% dividend which is very healthy
  • institutions own 85% of outstanding shares and funds have been net buyers in recent weeks
  • price popped higher out of a 5-month base in late June following an investor conference, suggesting strong demand
  • price recently cleared new 9-month highs and are higher by 67% over the past half year
  • MDCA carries a Zacks Rank of 2 (buy) and is estimated to beat estimates by 46% when it reports on August 3

The price chart below shows the breakouts we mentioned.  We like shares up to $10.75 with a stop-loss under $9.50, and a 1 year price target of $18.

- - -

Dr. Thomas K. Carr (aka "Dr. Stoxx")

Founder, CEO of DrStoxx.com and IXTHYSLetter.com

http://www.drstoxx.com

Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.